MIAMI, FLORIDA (Sept. 30, 2025) -- Research findings from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, are being presented this week at ASTRO 2025 – the American Society for Radiation Oncology's annual meeting in San Francisco.
Markus Bredel, M.D., Ph.D. , professor and chair of the Miller School's Department of Radiation Oncology, presented at the Presidential Symposium, focusing on "Precision Without Incision: The New Era of Functional Radiosurgery." His session, "Classical Movement Disorders and Connectomics: Image-Guided Radiosurgery Reimagined," explored innovative approaches to treating neurological conditions with advanced imaging and radiosurgery techniques.
"Advances in image-guided radiosurgery are transforming how we approach neurological disorders, allowing us to deliver precision treatment without invasive procedures," said Bredel. "Our work is redefining the boundaries of what's possible in radiation medicine and improving outcomes for patients with complex movement disorders."
Other presentations from Sylvester cover a range of critical topics, from innovative treatment modalities to personalized approaches that are transforming cancer care. Sylvester researchers are highlighted as moderators, as well as presenters of poster and oral presentations. For example:
- Amanda Rivera, M.D. , a Sylvester researcher and assistant professor of radiation oncology, discusses gaps in gynecologic cancer care.
- Alan Dal Pra, M.D. , a Sylvester researcher, associate professor of radiation oncology and director of clinical research, explores biomarker breakthroughs in prostate cancer as a discussant at the conference.
- In a plenary session, Matthew Abramowitz, M.D. , associate professor of radiation oncology, is also featured as a discussant.
- Alexandra Dreyfuss, M.D., presents a prospective, multicenter, phase II study on pembrolizumab and involved-site radiation therapy for Hodgkin lymphoma, highlighting new protocols and clinical trials that are shaping the future of hematologic radiation therapy.
"Our presence at ASTRO this year is a testament to our relentless pursuit of precision and progress in radiation medicine," said Bredel. "Our teams are not only advancing the science but also reimagining how we deliver care to improve outcomes for every patient."
